Bills
H.R.6092

H.R.6092: Veteran's Prostate Cancer Treatment and Research Act

Read the bill

About This Bill

Introduced March 5, 2020
Latest Major Action Sept. 23, 2020

Bill Sponsor

Neal Dunn (R-Fla.)

Bill Cosponsors

3 (2 Democrats, 1 Republican)

Bill Versions

Referred in Senate - Sept. 23, 2020
Engrossed in House - Sept. 22, 2020
Introduced in House - March 5, 2020

Bill Summary

Veteran's Prostate Cancer Treatment and Research Act This bill requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer. Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 8 statements associated with H.R.6092.

See statements

Bill Actions

Date	Description
Sept. 23, 2020	Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
Sept. 22, 2020	Motion to reconsider laid on the table Agreed to without objection.
Sept. 22, 2020	Voice Vote in the House On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4684-4685)
Sept. 22, 2020	DEBATE - The House proceeded with forty minutes of debate on H.R. 6092.
Sept. 22, 2020	Considered under suspension of the rules. (consideration: CR H4682-4685)
Sept. 22, 2020	Mr. Takano moved to suspend the rules and pass the bill, as amended.
Sept. 17, 2020	Ordered to be Reported by Voice Vote.
Sept. 17, 2020	Committee Consideration and Mark-up Session Held.
Sept. 10, 2020	Committee Hearings Held.
March 5, 2020	Referred to the House Committee on Veterans' Affairs.
March 5, 2020	Introduced in the House by Neal Dunn (R-Fla.)

Legislators

Bills

Statements

Lobbying

Travel